Logo
    Search podcasts and episodes

    pharmaceutical

    Explore "pharmaceutical" with insightful episodes like "Can Ozempic Maker Novo Nordisk Keep Up Its Momentum?" and "Moderna's CFO on How to Allocate Capital in Big Pharma" from podcasts like ""WSJ What’s News" and "Odd Lots"" and more!

    Episodes (2)

    Can Ozempic Maker Novo Nordisk Keep Up Its Momentum?

    Can Ozempic Maker Novo Nordisk Keep Up Its Momentum?
    A.M. Edition for May 2. Danish pharmaceutical giant Novo Nordisk upped its full-year guidance today as it reported continued strong demand for its blockbuster weight-loss and diabetes drugs. Barclays analyst Emily Field discusses where the drugmaker could go from here. Plus, Exxon Mobil reaches an agreement to close its $60 billion merger with Pioneer. And TikTok strikes a licensing deal to return Universal Music artists to the platform. Luke Vargas hosts. Listening on Google Podcasts? Here's our guide for switching to a different podcast player. Learn more about your ad choices. Visit megaphone.fm/adchoices

    Moderna's CFO on How to Allocate Capital in Big Pharma

    Moderna's CFO on How to Allocate Capital in Big Pharma

    The pharmaceutical space is characterized by extreme uncertainty. You never know what drugs are going to pan out. The lead time for development is extremely long. Market size is inherently unknowable. And the regulatory and pricing climate is constantly changing. So, how does a company decide where to invest its cash? On this episode, we speak with Moderna's chief financial officer, Jamey Mock, about how he views the problem. He explains the process by which the vaccine maker chooses which bets to make, how changing fortunes within the stock market affect corporate decision-making and the role of the government in accelerating progress and de-risking investment.

    See omnystudio.com/listener for privacy information.